Skip to main content
OpenTrials

Clinical trial condition

Movement Disorders

Explore clinical trials studying Movement Disorders. Study availability and eligibility vary by location and protocol.

4,245 public trials 787 recruiting studies
Refine in advanced search Browse all conditions

Movement Disorders trial results

Completed

OpicApone Sleep dISorder

NCT04986995

Conditions
Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +6 more
Locations
  • Hospital da Senhora da Oliveira - Guimarães, E.P.E, Serviço de Neurologia Guimarães, Portugal
View Trial Details
Completed

eArly levoDopa With Opicapone in Parkinson's paTients wIth motOr fluctuatioNs.

NCT04990284

Conditions
Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +6 more
Locations
  • Universitaetsklinikum Freiburg Freiburg im Breisgau, Baden-Wurttemberg, Germany
  • Parkinson-Klinik Ortenau GmbH&Co KG Wolfach, Baden-Wurttemberg, Germany
  • Klinik Haag i. OB Haag in Oberbayern, Bavaria, Germany
  • Universitaetsklinikum Wuerzburg Würzburg, Bavaria, Germany
View all 25 locations
View Trial Details
Completed

The ADAPT-study: Measuring Physical Performance Using Wearable Sensors in Parkinson's Disease and COPD (ADAPT)

NCT05756075

Conditions
Basal Ganglia Diseases, Behavior, Brain Diseases, +17 more
Locations
  • Paca Aalsmeer, Netherlands
  • Gezondheidscentrum Marne Amstelveen, Netherlands
  • Fysiotherapie Heusdenhout Breda, Netherlands
  • Praktijk Graaf Hendrik III Laan Breda, Netherlands
View all 28 locations
View Trial Details
Completed

PRidopidine's Outcome On Function in Huntington Disease, PROOF- HD

NCT04556656

Conditions
Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +13 more
Locations
  • Prilenia Investigational Site (Site 061) Davis, California, United States
  • Prilenia Investigational Site (Site 051) San Diego, California, United States
  • Prilenia Investigational Site (Site 343) Englewood, Colorado, United States
  • Prilenia Investigational Site (Site 333) Washington D.C., District of Columbia, United States
View all 58 locations
View Trial Details

Related conditions